Does Cosentyx Cause Fatigue?
Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, lists fatigue as a possible side effect in clinical data, though it's not among the most common ones like upper respiratory infections or diarrhea. In trials, fatigue occurred in about 3-6% of patients, similar to placebo rates in some studies, suggesting it may not always be drug-related.[1][2]
How Common Is Fatigue with Cosentyx?
Post-marketing reports and patient registries show fatigue in roughly 2-5% of users, often mild and transient. It's more frequently reported in the first few months of treatment. Real-world data from sources like the FDA's FAERS database notes hundreds of fatigue cases linked to secukinumab, but causality isn't always confirmed due to confounding factors like underlying autoimmune conditions.[3]
Why Might Cosentyx Lead to Fatigue?
Fatigue can stem from the drug's immune modulation, which might temporarily disrupt energy levels, or from infections it doesn't fully prevent. It could also relate to the disease itself—psoriasis and arthritis patients often report baseline fatigue that persists or worsens initially on biologics.[1][4]
What Do Patients Report About Fatigue on Cosentyx?
User forums and reviews (e.g., Drugs.com, WebMD) show mixed experiences: some note new or worsened fatigue resolving after dose adjustment, while others attribute it to concurrent meds or lifestyle. About 10-15% of reviewers mention tiredness, rating it lower than injection-site reactions.[5]
When Should You Worry About Fatigue on Cosentyx?
Mild fatigue is common and often improves, but severe or persistent cases warrant checking for infections, anemia, or thyroid issues—report to your doctor if it interferes with daily life. No black-box warnings tie Cosentyx directly to chronic fatigue syndrome.[2][3]
Alternatives If Fatigue Persists
Switching biologics like Humira (adalimumab) or Stelara (ustekinumab) may help, as their fatigue profiles differ slightly (Humira: ~4%; Stelara: ~3%). TNF inhibitors sometimes cause less immune-related tiredness but more infection risk.[1][6]
[1]: Cosentyx Prescribing Information (Novartis)
[2]: FDA Label for Secukinumab
[3]: FDA FAERS Database
[4]: ClinicalTrials.gov (SECURE-ERA Study)
[5]: Drugs.com Cosentyx Reviews
[6]: DrugPatentWatch.com - Secukinumab Competitors